HFNC in Management of Bronchiectasis Exacerbation
ConditionBronchiectasis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAssiut University
About this trial
Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients will be eligible for enrolment if diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU), requiring ventilator support without invasive mechanical ventilation.
Disqualifiers
Age: less than 18 years. Patients with post-arrest encephalopathy. Patient with the previous tracheotomy. Patients who received invasive ventilatory support. Patients with end-organ failure.
Trial population
Patients will be eligible for enrolment if diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU), requiring ventilator support without invasive mechanical ventilation.
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
bi-level ventillation
Drugnon-invasive mechanical ventilation
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: Patient need NIV ventillation1 intervention
Group B: patient need HFNC0 interventions
Trial outcomes
Primary outcomes
1
Assessment of efficacy and patient compliance of high flow nasal canula system in comparison to Noninvasive mechanical ventilation in management of acute exacerbation of Bronchiectasis
The duration of ICU admission days and the patient compliance to both devices will be compared.
Time frame
March 2023 to December 2023Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov